Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Buyback Yield | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares |
---|---|---|---|
6/30/2025 | -6.87% | $ 631.05M | $ 43.34M |
3/31/2025 | -15.43% | $ 609.06M | $ 93.99M |
12/31/2024 | -18.47% | $ 502.94M | $ 92.88M |
9/30/2024 | -15.38% | $ 604.92M | $ 93.05M |
6/30/2024 | 0.6% | $ 888.53M | $ -5.29M |
3/31/2024 | 2.51% | $ 716.57M | $ -17.96M |
12/31/2023 | 7.61% | $ 624.92M | $ -47.53M |
9/30/2023 | 10.31% | $ 430.52M | $ -44.37M |
6/30/2023 | 8.54% | $ 490.03M | $ -41.83M |
3/31/2023 | 5.32% | $ 549.88M | $ -29.28M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity) / Market Cap
(=) Buyback Yield
Buyback Yield for ANAPTYSBIO INC is calculated as follows: (-1 * CF - Equity [ $ 2.13M ]) / Market Cap [ $ 810.32M ]
(=) Buyback Yield [ -0.26% ]
Minimum
Dec 31, 2024
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.28K |
---|---|
min | -8.43% |
max | 8.46% |
average | 0.64% |
median | 0.01% |
std | 2.71% |